ASX 50

Tax policy no longer subsidises mediocre returns and lazy strategy and replacing them will be a positive change for smart investors

Australian shares remain 'tricky' as profit warnings continue to be issued, but in the background AI beneficiaries are making a come-back

As the big banks hit record highs, the experts reveal where they're hunting for value in ASX financials.

Seneca’s Luke Laretive explains what separates genuine 10-baggers from market hype, and why patience matters most.

As AI drives power demand, hear Jason explore the energy war, semiconductors, P.Credit, geopolitics, CCY, capital flows & where to allocate.

Australia's greatest blue chip has lost two-thirds of its value — how did the brokers get it so wrong, and could you have seen it coming?

Dispersions in valuations both locally and globally represent great opportunities for investors with the conviction to take a position.

The reset has created winners and losers. From small caps to global leaders, four experts share where they see value emerging in healthcare.

The Macquarie Conference has become one of the must-attend events in every Australian fund manager’s diary. In this podcast IML portfolio managers Daniel Moore and...

Julia Weng (Paradice) and Hamish FitzSimons (AllianceBernstein) diagnose ASX healthcare's brutal year and name the stocks set for recovery

AI didn't kill ASX SaaS stocks – it killed the multiples investors would pay for them. That distinction could make or break your portfolio.

Stocks, ETFs and sectors investors are watching as inflation and rate pressures return.

Does "sell in May" still hold? Plus, broker calls on stocks including RMD, FMG and BOE.

Seven fund managers walked into a sell-off and came out with a shopping list. Here are the 16 stocks they're backing.

As investors pile into AI, Alvia’s Chris Scarpato is running for the hills and building an anti-AI playbook. Here’s why.

Geopolitical shocks are no longer rare. Three fund managers explain how to position portfolios as uncertainty becomes the baseline.

Livewire's Carl Capolingua and Chris Conway have built a process for identifying growth stocks - they put it into practice here.

The market is not as 'expensive' at it seems at face value, but there is risk, tangible and significant, from profit warnings.

The record share price for the Big Australian looks justifiable as ex-CEO Mike Henry's copper and potash vision starts to bear fruit

How passive investing has permanently changed market structure — and why sophisticated tools are now the price of survival

Plus, PMET says caesium and tantalum credits will make its spodumene ‘very, very cheap’

Portfolio manager Andrew Martin on how the firm finds stocks with genuine earnings momentum.

Morningstar sees broad undervaluation across the market – and highlights where to look for opportunities.

Your brain lies to you about prices, and it's probably costing you money!